OraSure Technologies Yönetim

Yönetim kriter kontrolleri 3/4

OraSure Technologies CEO'su Carrie Eglinton Manner, Jun2022 tarihinde atandı, in görev süresi 2.42 yıldır. in toplam yıllık tazminatı $ 6.70M olup, şirket hissesi ve opsiyonları dahil olmak üzere 10.8% maaş ve 89.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 1.58% ine doğrudan sahiptir ve bu hisseler $ 4.50M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.4 yıl ve 3 yıldır.

Anahtar bilgiler

Carrie Eglinton Manner

İcra Kurulu Başkanı

US$6.7m

Toplam tazminat

CEO maaş yüzdesi	10.8%
CEO görev süresi	2.4yrs
CEO sahipliği	1.6%
Yönetim ortalama görev süresi	2.4yrs
Yönetim Kurulu ortalama görev süresi	3yrs

Son yönetim güncellemeleri

Recent updates

Some May Be Optimistic About OraSure Technologies' (NASDAQ:OSUR) Earnings

Nov 14

Here's What Analysts Are Forecasting For OraSure Technologies, Inc. (NASDAQ:OSUR) After Its Third-Quarter Results

Nov 08

OraSure: An NCAV Diamond In The COVID Rough

Nov 04

OraSure Technologies: Nursing A COVID-19 Hangover

Sep 10

OraSure Technologies, Inc. (NASDAQ:OSUR) Just Reported Earnings, And Analysts Cut Their Target Price

May 11

Lacklustre Performance Is Driving OraSure Technologies, Inc.'s (NASDAQ:OSUR) Low P/S

Apr 17

Earnings Beat: OraSure Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Mar 01

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Feb 29

OraSure Technologies, Inc.'s (NASDAQ:OSUR) Business And Shares Still Trailing The Industry

Dec 20

Returns On Capital At OraSure Technologies (NASDAQ:OSUR) Have Stalled

Nov 08

Industry Analysts Just Upgraded Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Forecasts By 14%

Aug 09

Analysts Have Just Cut Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Estimates By 12%

May 16

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

May 13

Party Time: Brokers Just Made Major Increases To Their OraSure Technologies, Inc. (NASDAQ:OSUR) Earnings Forecasts

Feb 17

Are OraSure Technologies, Inc. (NASDAQ:OSUR) Investors Paying Above The Intrinsic Value?

Jun 14

OraSure: Not So Sure With Softening Fundamentals, Fairly Priced At $2.54

Jun 10

CEO Tazminat Analizi

Carrie Eglinton Manner'un ücretlendirmesi OraSure Technologies'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	US$11m
Jun 30 2024	n/a	n/a	US$27m
Mar 31 2024	n/a	n/a	US$23m
Dec 31 2023	US$7m	US$721k	US$54m
Sep 30 2023	n/a	n/a	US$49m
Jun 30 2023	n/a	n/a	US$44m
Mar 31 2023	n/a	n/a	US$30m
Dec 31 2022	US$7m	US$377k	-US$17m

Tazminat ve Piyasa: Carrie 'nin toplam tazminatı ($USD 6.70M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 1.47M ).

Tazminat ve Kazançlar: Carrie 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Carrie Eglinton Manner (49 yo)

2.4yrs

Görev süresi

US$6,701,767

Tazminat

Ms. Carrie Eglinton Manner serves as President, Chief Executive Officer & Director of OraSure Technologies, Inc. since June 04, 2022. She joined OraSure Technologies, Inc. on June 04, 2022. She serves as a...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Carrie Eglinton Manner	President	2.4yrs	US$6.70m	1.58% $ 4.5m
Kenneth McGrath	Chief Financial Officer	2.3yrs	US$1.53m	0.41% $ 1.2m
Kathleen Weber	Chief Product Officer	12yrs	US$1.67m	0.40% $ 1.1m
Michele Anthony	Senior VP	6.1yrs	Veri yok	0.14% $ 388.4k
Rafal Iwasiow	Vice President of Science	1.8yrs	Veri yok	Veri yok
Jason Plagman	Vice President of Investor Relations	no data	Veri yok	Veri yok
Stefano Taucer	General Counsel & Corporate Secretary	2.3yrs	Veri yok	Veri yok
David Rappaport	Senior Vice President Corporate Development	2.8yrs	Veri yok	Veri yok
Amy Steigerwalt	Senior Vice President of Human Resources	2.8yrs	Veri yok	Veri yok
Zachary Wert	Senior Vice President of Global Operations	2.3yrs	Veri yok	Veri yok
Trace Custer	Senior Vice President of Quality & Regulatory	2yrs	Veri yok	Veri yok

2.4yrs

Ortalama Görev Süresi

50yo

Ortalama Yaş

Deneyimli Yönetim: OSUR 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.4 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Carrie Eglinton Manner	President	2.4yrs	US$6.70m	1.58% $ 4.5m
David Shulkin	Independent Director	4.6yrs	US$170.00k	0.081% $ 229.8k
Mara Aspinall	Independent Chair of the Board	7.4yrs	US$228.99k	0.15% $ 435.9k
Nancy Gagliano	Independent Director	3yrs	US$183.12k	0.11% $ 300.1k
Robert McMahon	Independent Director	1.3yrs	US$135.93k	0.057% $ 162.5k
John Kenny	Independent Director	less than a year	Veri yok	0.031% $ 88.6k
Lelio Marmora	Independent Director	4.4yrs	US$170.00k	0.081% $ 231.3k

3.0yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: OSUR 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3 yıldır).

OraSure Technologies Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

OraSure Technologies, Inc. Appoints John P. Kenny as New Member of the Board, Member of the Nominating and Corporate Governance Committee

OraSure Technologies, Inc., Annual General Meeting, May 14, 2024

Chief Product Officer notifies of intention to sell stock

OraSure Technologies, Inc. Announces Election of Robert W. McMahon to its Board of Directors, Effective July 31, 2023

Chief Financial Officer recently bought US$493k worth of stock

High number of new directors

Recent updates

Some May Be Optimistic About OraSure Technologies' (NASDAQ:OSUR) Earnings

Here's What Analysts Are Forecasting For OraSure Technologies, Inc. (NASDAQ:OSUR) After Its Third-Quarter Results

OraSure Technologies, Inc. Provides Revenue Guidance for the Fourth Quarter of 2024

New minor risk - Profit margin trend

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

OraSure: An NCAV Diamond In The COVID Rough

OraSure Technologies, Inc. to Report Q3, 2024 Results on Nov 06, 2024

OraSure Technologies, Inc. Appoints John P. Kenny as New Member of the Board, Member of the Nominating and Corporate Governance Committee

OraSure Technologies: Nursing A COVID-19 Hangover

Consensus EPS estimates upgraded to US$0.098 loss

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

OraSure Technologies, Inc. Provides Revenue Guidance for the Third Quarter of 2024

OraSure Technologies, Inc. to Report Q2, 2024 Results on Aug 06, 2024

Price target decreased by 7.5% to US$6.13

Consensus EPS estimates fall by 54%

Price target decreased by 7.9% to US$6.95

OraSure Technologies, Inc. (NASDAQ:OSUR) Just Reported Earnings, And Analysts Cut Their Target Price

New minor risk - Shareholder dilution

OraSure Technologies, Inc. Provides Revenue Guidance for the Second Quarter of 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Lacklustre Performance Is Driving OraSure Technologies, Inc.'s (NASDAQ:OSUR) Low P/S

New minor risk - Shareholder dilution

OraSure Technologies, Inc., Annual General Meeting, May 14, 2024

Earnings Beat: OraSure Technologies, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

New minor risk - Earnings quality

OraSure Technologies, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Full year 2023 earnings: EPS exceeds analyst expectations

OraSure Technologies, Inc. to Report Fiscal Year 2023 Results on Feb 27, 2024

Chief Product Officer notifies of intention to sell stock

OraSure Technologies, Inc.'s (NASDAQ:OSUR) Business And Shares Still Trailing The Industry

Investor sentiment improves as stock rises 18%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

OraSure Technologies, Inc. Provides Financial Guidance for the Fourth Quarter 2023

Returns On Capital At OraSure Technologies (NASDAQ:OSUR) Have Stalled

OraSure Technologies, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Investor sentiment improves as stock rises 41%

Industry Analysts Just Upgraded Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Forecasts By 14%

New minor risk - Share price stability

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

OraSure Technologies, Inc. Provides Revenue Guidance for the Third Quarter of 2023

OraSure Technologies, Inc. to Report Q2, 2023 Results on Aug 03, 2023

OraSure Technologies, Inc. Announces Election of Robert W. McMahon to its Board of Directors, Effective July 31, 2023

Price target decreased by 7.2% to US$6.45

OraSure Technologies, Inc. Announces Study Concludes Self-Sampling Using Colli-Pee® Device for HPV Screening Is Both Cost Effective and Could Improve Patient Access

Investor sentiment improves as stock rises 17%

Chief Financial Officer recently bought US$493k worth of stock

Investor sentiment deteriorates as stock falls 22%

Analysts Have Just Cut Their OraSure Technologies, Inc. (NASDAQ:OSUR) Revenue Estimates By 12%

Return Trends At OraSure Technologies (NASDAQ:OSUR) Aren't Appealing

Price target increased by 13% to US$6.95

Orasure Technologies, Inc. Provides Earnings Guidance for the Second Quarter 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

OraSure Technologies, Inc. to Report Q1, 2023 Results on May 10, 2023

Party Time: Brokers Just Made Major Increases To Their OraSure Technologies, Inc. (NASDAQ:OSUR) Earnings Forecasts

Price target increased by 8.0% to US$5.88

Full year 2022 earnings: EPS and revenues exceed analyst expectations

OraSure Technologies, Inc. Provides Revenue Guidance for the First Quarter of 2023

OraSure Technologies, Inc. to Report Q4, 2022 Results on Feb 14, 2023

We're Not Very Worried About OraSure Technologies' (NASDAQ:OSUR) Cash Burn Rate

Consensus estimates of losses per share improve by 69%

High number of new directors

OraSure Technologies, Inc. Announces Executive Changes

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

OraSure Technologies, Inc. Reports Goodwill and Long-Lived Assets Impairment Charges for the Third Quarter Ended September 30, 2022

Orasure Technologies Receives General Clearance for Its ORAcollect--Dx Device for over the Counter Use from the U.S. Food and Drug Administration

OraSure Technologies, Inc. Announces InteliSwab Covid-19 Rapid Test Now Available in Amazon’s Online Store

OraSure Technologies, Inc. to Report Q3, 2022 Results on Nov 08, 2022

OraSure wins $8.6M government contract for next-gen Ebola test